Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
a.k.a. subacute necrotizing encephalomyelopathy
Genetically heterogeneous mitochondrial disorder characterized by progressive neurodegeneration
Best imaging: MR with DWI/MRS
Bilateral, symmetric ↑ T2/FLAIR corpora striata (putamen > caudate) > globi pallidi, periaqueductal gray matter, substantia nigra/subthalamic nuclei, dorsal pons, cerebellar nuclei
Reduced diffusion in regions of acute disease
Lactate peak often present on MRS; may be large
Uncommon appearance: Predominant white matter disease (simulates leukodystrophy)
Profound perinatal asphyxia
Mitochondrial encephalopathy, lactic acidosis, stroke-like episodes (MELAS)
Glutaric aciduria type 1
Wilson disease
Bioenergetic failure (ATP loss) and production of reactive oxygen species likely key factors in mitochondria-mediated cell apoptosis
50-75% of patients with Leigh syndrome have detectable biochemical or molecular abnormality
Presentation
Psychomotor delay/regression, dystonia/hypotonia, ataxia
Other: Ophthalmoplegia, seizures, lactic acidosis
Prenatal diagnosis: Chorionic villus sampling (mutations and biochemical defects)
Majority present by age 2 years
. Foci of hyperintensity are also present in the medial thalami
, a typical location of involvement in Leigh syndrome.
at 1.3 ppm. The identification of a lactate peak supports the diagnosis of mitochondrial disease but is variably present.
bilaterally. In addition, the genu
and splenium
of the corpus callosum are affected. Note that foci of unaffected tissue
are present in the putamina; heterogeneous involvement is common.
. This is another common site of involvement in Leigh syndrome.
Leigh syndrome (LS)
Subacute necrotizing encephalomyelopathy
Genetically heterogeneous mitochondrial disorder characterized by progressive neurodegeneration
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here